DNA methylation analysis in MSC therapy

Analysis of DNA methylation changes in bone marrow mesenchymal stem cell therapy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1010220030

Enrollment

Registered

2022-12-23

Start date

2022-12-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain injury etc

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients newly admitted to Sapporo Medical University Hospital for the administration of MSCs who are able to obtain consent will be included. The scope of the study includes physician-initiated clinical trials using MSCs (STR01-01, STR01-02, STR01-03, STR01-04, STR01-05, and STR01-08 studies) and patients undergoing treatment with Stemilac Injection who are judged to be capable of safely obtaining blood samples. Subjects.

Exclusion criteria

Exclusion criteria: (1) Cases in which consent to participate in the research could not be obtained. (2). cases in which it is considered difficult to collect specimens safely.

Design outcomes

Primary

Measure	Time frame
DNAge (DNAge Epigenetic Aging Clock)	—

Contacts

Public ContactMasanori Sasaki

Sapporo Medical University

msasaki@sapmed.ac.jp+81-116112111

Outcome results